These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1016 related items for PubMed ID: 14689061

  • 1. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M, Kusenda J, Babusíková O.
    Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
    [Abstract] [Full Text] [Related]

  • 2. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
    Klobusická M, Kusenda J, Babusíková O.
    Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
    [Abstract] [Full Text] [Related]

  • 3. The study of AgNOR proteins in leukemias: diagnostic value and correlation to S-phase cell fraction.
    Klobusická M, Babusíková O, Mesárosová A, Kusenda J, Glasová M.
    Neoplasma; 1996; 43(6):397-401. PubMed ID: 8996564
    [Abstract] [Full Text] [Related]

  • 4. Expression of p53 and bcl-2 proteins in acute leukemias: an immunocytochemical study.
    Klobusická M, Kusenda J, Babusíkova O.
    Neoplasma; 2001; 48(6):489-95. PubMed ID: 11949843
    [Abstract] [Full Text] [Related]

  • 5. P53 protein expression in human leukemia and lymphoma cells.
    Koníková E, Kusenda J.
    Neoplasma; 2001; 48(4):290-8. PubMed ID: 11712681
    [Abstract] [Full Text] [Related]

  • 6. Differential expression of survivin in bone marrow cells from patients with acute lymphocytic leukemia and chronic lymphocytic leukemia.
    Nakagawa Y, Yamaguchi S, Hasegawa M, Nemoto T, Inoue M, Suzuki K, Hirokawa K, Kitagawa M.
    Leuk Res; 2004 May; 28(5):487-94. PubMed ID: 15068902
    [Abstract] [Full Text] [Related]

  • 7. The relationship between argyrophilic proteins and some immunophenotypic markers in acute leukemia cells.
    Klobusická M, Babusíková O.
    Neoplasma; 1997 May; 44(6):356-60. PubMed ID: 9605007
    [Abstract] [Full Text] [Related]

  • 8. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M, Mackenzie K, Drullinsky P, Silver RT, Moore MA.
    Cancer Res; 2000 Feb 01; 60(3):610-7. PubMed ID: 10676644
    [Abstract] [Full Text] [Related]

  • 9. Coexpression of p53 protein and MDR functional phenotype in leukemias: the predominant association in chronic myeloid leukemia.
    Cavalcanti GB, Vasconcelos FC, Pinto de Faria G, Scheiner MA, de Almeida Dobbin J, Klumb CE, Maia RC.
    Cytometry B Clin Cytom; 2004 Sep 01; 61(1):1-8. PubMed ID: 15351976
    [Abstract] [Full Text] [Related]

  • 10. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
    Molica S, Mannella A, Dattilo A, Levato D, Iuliano F, Peta A, Consarino C, Magro S.
    Haematologica; 1996 Sep 01; 81(4):302-9. PubMed ID: 8870373
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V, Capalbo S, Lapietra A, Pavone V, Guarini A, Specchia G.
    Haematologica; 1999 Mar 01; 84(3):212-7. PubMed ID: 10189384
    [Abstract] [Full Text] [Related]

  • 12. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
    Strnad M, Brajuskovic G, Strelic N, Todoric-Zivanovic B, Stamatovic D, Tatomirovic Z, Magic Z.
    J BUON; 2008 Mar 01; 13(3):403-8. PubMed ID: 18979557
    [Abstract] [Full Text] [Related]

  • 13. Bcl-2 expression in acute myelogenous leukemia: the relation to myeloid antigen expression and response to therapy in Iranian patients.
    Daneshbod Y, Amirghofran Z, Tabei SZ.
    Neoplasma; 2005 Mar 01; 52(2):109-14. PubMed ID: 15800708
    [Abstract] [Full Text] [Related]

  • 14. Spectrum of argyrophilic nucleolar organizer region (AgNOR) staining patterns in chronic and transformed B-cell leukemias.
    Nikicicz EP, Norback DH.
    Arch Pathol Lab Med; 1992 Mar 01; 116(3):265-8. PubMed ID: 1536612
    [Abstract] [Full Text] [Related]

  • 15. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
    Schade U, Bock O, Vornhusen S, Jäger A, Büsche G, Lehmann U, Kreipe H.
    Hum Pathol; 2006 Sep 01; 37(9):1153-61. PubMed ID: 16938520
    [Abstract] [Full Text] [Related]

  • 16. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z, Takahashi M, Aoki S, Toba K, Liu A, Osman Y, Takahashi H, Tsukada N, Suzuki N, Nikkuni K, Furukawa T, Koike T, Aizawa Y.
    J Exp Clin Cancer Res; 1998 Sep 01; 17(3):251-8. PubMed ID: 9894758
    [Abstract] [Full Text] [Related]

  • 17. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I, Planinc-Peraica A, Ostojić Kolonić S, Radić-Kristo D, Milas M, Vrhovac R, Sustercić D, Minigo H, Jaksić B.
    Acta Med Croatica; 2008 Oct 01; 62(4):351-64. PubMed ID: 19205412
    [Abstract] [Full Text] [Related]

  • 18. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
    Graf M, Reif S, Hecht K, Pelka-Fleischer R, Pfister K, Schmetzer H.
    Am J Hematol; 2005 May 01; 79(1):26-35. PubMed ID: 15849776
    [Abstract] [Full Text] [Related]

  • 19. Relationship between AgNORs, MIB-1 and oncogene expression in male breast carcinoma and papillary superficial bladder neoplasm.
    Pich A, Margaria E, Chiusa L, Bortolin P, Palestro G.
    Oncol Rep; 2003 May 01; 10(5):1329-35. PubMed ID: 12883702
    [Abstract] [Full Text] [Related]

  • 20. Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis.
    Nagy B, Ferrer A, Larramendy ML, Galimberti S, Aalto Y, Casas S, Vilpo J, Ruutu T, Vettenranta K, Franssila K, Knuutila S.
    Haematologica; 2003 Jun 01; 88(6):654-8. PubMed ID: 12801841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.